\n| LDH-5<\/td>\n | M\u2084<\/td>\n | Liver, skeletal muscle<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n Clinical significance:<\/strong> LDH-1 increases significantly in the bloodstream after a myocardial infarction (heart attack), because damaged heart cells release this cytoplasmic isoenzyme. When LDH-5 > LDH-4, it may indicate liver disease. In gel electrophoresis, LDH-1 shows the highest anodic mobility and LDH-5 the lowest.<\/p>\nKinetic difference:<\/strong> The H subunit-rich isoforms (LDH-1) have a lower Km for pyruvate<\/strong>, meaning higher affinity. The M subunit-rich isoforms (LDH-5) have a higher Km<\/strong>, suited for rapidly metabolizing lactate in working muscles.<\/p>\n2. Creatine Kinase \/ Creatine Phosphokinase (CK\/CPK)<\/h4>\nCK catalyzes the reversible transfer of a phosphate group from phosphocreatine to ADP, regenerating ATP. It is a dimer<\/strong> composed of two subunit types B (brain)<\/strong> and M (muscle)<\/strong> forming three isoenzymes:<\/p>\n\n \n\n\n| Isoform<\/th>\n | Composition<\/th>\n | Primary Location<\/th>\n | Clinical Significance<\/th>\n<\/tr>\n<\/thead>\n | \n\n| CK-BB (CK-1)<\/td>\n | BB<\/td>\n | Brain, lungs<\/td>\n | Elevated in CNS diseases, stroke<\/td>\n<\/tr>\n | \n| CK-MB (CK-2)<\/td>\n | MB<\/td>\n | Heart muscle<\/td>\n | Elevated in acute myocardial infarction<\/td>\n<\/tr>\n | \n| CK-MM (CK-3)<\/td>\n | MM<\/td>\n | Skeletal muscle<\/td>\n | Elevated in muscular dystrophy, crush injuries<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n CK-MB is the most diagnostically significant isoform in cardiology. Its elevation, along with troponin, is a key marker of myocardial infarction.<\/p>\n 3. Alkaline Phosphatase (ALP)<\/h4>\nALP exists as multiple isoenzymes that differ primarily in their carbohydrate (glycosylation) content<\/strong> specifically in sialic acid residues \u2014 rather than in their polypeptide backbone. This makes ALP isoforms a prime example of secondary isozymes<\/strong>. Six major isoforms have been identified in humans. Elevated liver ALP (\u03b1\u2082-heat labile form) suggests hepatitis, while elevated bone ALP suggests bone disease or Paget’s disease.<\/p>\n4. Hexokinase vs. Glucokinase \u2014 A Metabolic Regulation Classic<\/h4>\nHexokinase and glucokinase are both isozymes that phosphorylate glucose to glucose-6-phosphate, but they behave very differently:<\/p>\n \n \n\n\n| Property<\/th>\n | Hexokinase (Types I\u2013III)<\/th>\n | Glucokinase (Type IV)<\/th>\n<\/tr>\n<\/thead>\n | \n\n| Km for glucose<\/td>\n | Low (~0.1 mM)<\/td>\n | High (~10 mM)<\/td>\n<\/tr>\n | \n| Inhibition by G-6-P<\/td>\n | Yes (product inhibition)<\/td>\n | No<\/td>\n<\/tr>\n | \n| Tissue<\/td>\n | Most tissues<\/td>\n | Liver, pancreatic \u03b2-cells<\/td>\n<\/tr>\n | \n| Physiological role<\/td>\n | Glucose uptake at low concentrations<\/td>\n | Glucose sensor; acts at high post-meal glucose levels<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n This pair illustrates perfectly how isozymes allow tissue-specific metabolic control hexokinase ensures constant low-level glucose phosphorylation in all tissues, while glucokinase acts as a glucose sensor in the liver and triggers insulin release from the pancreas only after a meal.<\/p>\n 5. Pyruvate Kinase (PK)<\/h4>\nPyruvate kinase exists in at least four isoforms (PK-L, PK-R, PK-M1, PK-M2) expressed in different tissues. PK-M2, expressed in rapidly proliferating cells including cancer cells, supports aerobic glycolysis (the Warburg effect) a connection increasingly tested in CSIR NET questions linking metabolism and cancer biology.<\/p>\n
\nHow Are Isozymes Separated and Identified?<\/h3>\nGel electrophoresis<\/strong> (particularly native PAGE) is the primary technique for separating isozymes. Because isozymes differ in amino acid sequence, they carry different net charges and have different molecular weights, causing them to migrate at different rates in an electric field. Activity staining after electrophoresis allows specific identification of each isoform.<\/p>\nOther separation techniques include:<\/p>\n \n- Ion-exchange chromatography (e.g., DEAE-cellulose)<\/li>\n
- Immunological assays (ELISA, immunoelectrophoresis)<\/li>\n
- Isoelectric focusing<\/li>\n<\/ul>\n
The IUPAC-IUB convention assigns the number 1 to the isoform with the greatest mobility toward the anode.<\/p>\n
\nWorked Example: CSIR NET-Style Question on Isozymes<\/h3>\nQuestion:<\/strong> A patient arrives at the emergency room with chest pain. Blood tests show elevated CK-MB and LDH-1. The ratio of LDH-1 to LDH-2 is greater than 1 (LDH flip). What does this pattern indicate, and what is the biochemical basis?<\/p>\nAnswer and Explanation:<\/strong><\/p>\nThe elevated CK-MB (the cardiac isoform of creatine kinase) strongly suggests acute myocardial infarction<\/strong>. CK-MB is predominantly found in heart muscle, so its release into the bloodstream signals heart tissue damage.<\/p>\nThe LDH flip<\/strong> \u2014 where LDH-1 exceeds LDH-2 \u2014 is also characteristic of myocardial infarction. Normally, LDH-2 > LDH-1 in serum. The heart is rich in LDH-1 (H\u2084 subunit, high affinity for pyruvate). When cardiac cells are damaged, they release LDH-1 into circulation, reversing the normal ratio.<\/p>\nBiochemically, LDH-1 has a lower Km for pyruvate<\/strong> than LDH-5 because its four H subunits create an active site with higher substrate affinity. This suits aerobic heart tissue, which oxidizes lactate back to pyruvate for energy. The M-subunit-rich LDH-5 in skeletal muscle has a higher Km, suited for producing lactate rapidly under anaerobic conditions.<\/p>\nThis question integrates isozyme structure, kinetics, tissue distribution, and clinical application a hallmark of Part C CSIR NET questions.<\/p>\n
\nCommon Misconceptions About Isozymes<\/h3>\nMisconception 1: Isozymes and isoenzymes are different things.<\/strong> In current usage, the terms are interchangeable. Technically, some biochemists distinguish between them at the genetic level, but for CSIR NET purposes they refer to the same concept.<\/p>\nMisconception 2: All isozymes arise from different genes.<\/strong> Secondary isozymes (like ALP isoforms) arise from post-translational modification of the same gene product not from different genes.<\/p>\nMisconception 3: Isozymes perform identical functions in all tissues.<\/strong> Isozymes catalyze the same reaction, but their kinetic properties, regulatory behavior, and expression levels are tissue-specific \u2014 meaning their physiological role and contribution to metabolism can differ significantly.<\/p>\nMisconception 4: A lower Km always means a “better” enzyme.<\/strong> Lower Km means higher substrate affinity useful when substrates are scarce. Higher Km isozymes (like glucokinase) are not inferior; they are suited to respond only when substrate concentrations are high, serving as metabolic sensors.<\/p>\n
\nReal-World Applications of Isozymes<\/h3>\nClinical diagnostics<\/strong> remain the most exam-relevant application. Measuring specific isoenzyme levels in serum allows clinicians to identify which organ or tissue has been damaged without surgery. CK-MB for heart attacks, LDH-1 for myocardial infarction and hemolysis, and ALP isoforms for liver vs. bone disease are all standard diagnostic markers.<\/p>\nPopulation genetics and plant biology<\/strong> use isozyme electrophoresis as molecular markers to study genetic diversity, mating systems, and evolutionary relationships between species a cost-effective alternative to DNA-based markers for certain studies.<\/p>\nBiotechnology<\/strong> leverages isozyme diversity for enzyme engineering. Selecting or engineering isoforms with specific Km, pH, or temperature optima allows optimization of industrial biocatalysts for pharmaceutical, food, and biofuel applications.<\/p>\n
\nExam Strategy: How to Master Isozymes for CSIR NET<\/h3>\nBuild concept maps.<\/strong> Link each isozyme to its subunit composition, tissue distribution, kinetic properties, and clinical significance. The LDH and CK tables in this article are good starting points.<\/p>\nPractice Km-based calculations.<\/strong> CSIR NET Part B and C frequently present Km values for two isoforms and ask which has higher substrate affinity or which would be active at a given substrate concentration. Always remember: lower Km = higher affinity<\/strong>.<\/p>\nConnect isozymes to regulation.<\/strong> Every tissue-specific isozyme reflects a regulatory logic why does the heart need LDH-1 rather than LDH-5? Answering this type of “why” question demonstrates the deep understanding that Part C demands.<\/p>\nDo not skip clinical examples.<\/strong> Questions on CK-MB in myocardial infarction, LDH flip, and ALP in hepatitis appear regularly. These bridge basic biochemistry with clinical relevance a combination CSIR NET examiners favor.<\/p>\nUse previous years’ papers.<\/strong> Identify which isoenzyme examples have been tested before, how Km\/Vmax questions are framed, and how electrophoresis-based identification is tested.<\/p>\nAt VedPrep Chem Academy<\/strong>, our structured study materials on enzyme kinetics and regulation\u00a0 including expert-led sessions on isozymes, LDH and CK isoforms, and Km-based problem solving are designed to help you build exactly this level of exam-ready understanding.<\/p>\n
\n | | |